Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor α receptor: a new clinical target for STI571/Glivec

MLA

Claire Villalva, et al. “Chronic Myeloproliferative Disorders with Rearrangement of the Platelet-Derived Growth Factor α Receptor: A New Clinical Target for STI571/Glivec.” Oncogene, vol. 22, Aug. 2003, pp. 5702–06. EBSCOhost, https://doi.org/10.1038/sj.onc.1206543.

APA

Claire Villalva, Florence Armstrong, Georges Delsol, Pierre Brousset, Guy Laurent, Pascal Trempat, & Nicole Dastugue. (2003). Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor α receptor: a new clinical target for STI571/Glivec. Oncogene, 22, 5702–5706. https://doi.org/10.1038/sj.onc.1206543

Chicago

Claire Villalva, Florence Armstrong, Georges Delsol, Pierre Brousset, Guy Laurent, Pascal Trempat, and Nicole Dastugue. 2003. “Chronic Myeloproliferative Disorders with Rearrangement of the Platelet-Derived Growth Factor α Receptor: A New Clinical Target for STI571/Glivec.” Oncogene 22 (August): 5702–6. doi:10.1038/sj.onc.1206543.